Kazia Therapeutics Limited Profit Margin

Kazia Therapeutics Limited (KZIA) currently reports a profit margin of -1809.61% as of December 2025. That compares with -6443161.96% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 13.45%. Use the charts on this page to explore Kazia Therapeutics Limited's profit margin history and peer comparisons.

Kazia Therapeutics Limited's profit margin increased from -6443161.96% to -1809.61% — a 100.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kazia Therapeutics Limited's profit margin of -1809.61% is lower than the Healthcare sector average of 13.45%. That is roughly 13556.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Kazia Therapeutics Limited's current -1809.61% should be judged against Healthcare norms (sector average: 13.45%) and against KZIA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1809.61%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.45%. From there, open related valuation or income-statement pages for Kazia Therapeutics Limited, and consider following KZIA for alerts when major investors trade the stock.